Skip to main content
. 2017 Jun 20;40(9):1187–1193. doi: 10.2337/dc16-2754

Table 2.

Association between variability in HbA1c and GDS

HbA1c-SD IRR (95% CI) P value
Overall (n = 837)
 Model A 1.20 (1.001–1.44) 0.0485*
 Model B 1.22 (1.02–1.47) 0.0285*
 Model C 1.29 (1.07–1.55) 0.0078*
 Model D 1.24 (1.02–1.51) 0.0318*
 Model E 1.33 (1.04–1.70) 0.0230*
 Model F 1.31 (1.03–1.67) 0.0273*
Sample stratified by mean HbA1c ≤7 (n = 555)
 Model A 1.17 (0.82–1.67) 0.3939
 Model B 1.18 (0.82–1.68) 0.3728
 Model C 1.31 (0.90–1.89) 0.1550
 Model D 1.26 (0.86–1.83) 0.2341
 Model E 1.30 (0.87–1.93) 0.1979
 Model F 1.30 (0.88–1.92) 0.1943
Sample stratified by mean HbA1c >7 (n = 282)
 Model A 1.22 (0.93–1.61) 0.1516
 Model B 1.30 (0.98–1.71) 0.0650
 Model C 1.41 (1.07–1.86) 0.0139*
 Model D 1.40 (1.06–1.86) 0.0185*
 Model E 1.41 (1.02–1.94) 0.0351*
 Model F 1.41 (1.03–1.93) 0.0331*

IRR (95% CI) data were estimated using a negative binomial regression modeling score for the entire sample (n = 837) and stratified by mean HbA1c. Model A was unadjusted; model B was adjusted for age; model C was adjusted for age, years in the registry, years of education, and sex; model D was adjusted for age, years in the registry, years of education, sex, total cholesterol, systolic blood pressure, diastolic blood pressure, glomerular filtration rate (GFR), HDL, LDL, and diabetes medication group; model E was adjusted for age, years in the registry, years of education, sex, total cholesterol, systolic blood pressure, diastolic blood pressure, GFR, diabetes medication group, HDL, LDL, and mean HbA1c; and model F was adjusted for age, years in the registry, years of education, sex, total cholesterol, systolic blood pressure, diastolic blood pressure, GFR, diabetes medication group, mean HbA1c, HDL, LDL, and MMSE total score.

*Indicates statistical significance.